RACHEL RAMM: Open Payments
NPI 1689830440 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 34 payments from 9 companies in 2025. Trend: 2023 $665 · 2024 $1,015 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 14 | $224 |
| Astellas Pharma US Inc | 8 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| CooperSurgical, Inc. | 1 | $30 |
| Organon LLC | 1 | $29 |
| ABBVIE INC. | 1 | $23 |
| Exeltis, USA Inc. | 1 | $22 |
| Biogen, Inc. | 1 | $16 |
Products named: Veozah, MYFEMBREE, Mirena, Paragard T 380A, NEXPLANON, LILETTA, SLYND, Lynkuet.
Industry payments across NE — which companies pay providers there.
